“Imatinib treatment and pharmacogenotype CYP3A4 in relation with the clonal expansion Ph(+) in chronic myeloid leukemia (CML)”. (2008) Colombia Medica, 39(4), pp. 314–322. doi:10.25100/cm.v39i4.613.